Incannex Healthcare Inc. 8K

Incannex Healthcare Inc. received A$6.0 million and expects a further A$5.1 million in Australian R&D tax incentive refunds in 2026, bolstering its non-dilutive funding and financial flexibility.

Incannex Healthcare Inc. announced that it has received A$6,039,162.43 in cash under the Australian Government’s Research and Development Tax Incentive Program for FY25 and expects to receive an additional approximately A$5.1 million later in 2026, providing more than A$11.1 million in total non-dilutive funding this year. The company stated that these proceeds strengthen its already debt-free balance sheet, enhance financial flexibility, and will be used to support advancement of key clinical programs, including IHL-42X and PSX-001, as well as shareholder-focused capital allocation initiatives such as its active share repurchase program.

Filing Facts

CIK

1873875

Ticker

-

Form

8K

Source Type

sec

Accession

0001213900-26-067081

Alert Tier

6